ZNF772 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.11022302462516E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.44089209850063E-16 |
Normal-vs-Stage2 |
9.11937192427104E-13 |
Normal-vs-Stage3 |
<1E-12 |
Normal-vs-Stage4 |
1.62436730732907E-12 |
Stage1-vs-Stage2 |
7.769700E-02 |
Stage1-vs-Stage3 |
2.28810000002522E-06 |
Stage1-vs-Stage4 |
2.14459999758887E-08 |
Stage2-vs-Stage3 |
1.425630E-01 |
Stage2-vs-Stage4 |
1.827780E-02 |
Stage3-vs-Stage4 |
1.939190E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.6242562850266E-12 |
Normal-vs-AfricanAmerican |
2.00179872678063E-11 |
Normal-vs-Asian |
1.073640E-02 |
Caucasian-vs-AfricanAmerican |
4.860200E-01 |
Caucasian-vs-Asian |
1.765810E-01 |
AfricanAmerican-vs-Asian |
3.596600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
<1E-12 |
Normal-vs-Female |
1.62447832963153E-12 |
Male-vs-Female |
2.365900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.16360000004912E-06 |
Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
Normal-vs-Age(81-100Yrs) |
1.14408482687622E-12 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.227000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.226830E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.899800E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.484260E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.354400E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.834000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.375800E-03 |
Normal-vs-Grade 2 |
3.44169137633799E-15 |
Normal-vs-Grade 3 |
1.62458935193399E-12 |
Normal-vs-Grade 4 |
1.62458935193399E-12 |
Grade 1-vs-Grade 2 |
2.447000E-01 |
Grade 1-vs-Grade 3 |
8.201300E-03 |
Grade 1-vs-Grade 4 |
8.37650000029555E-07 |
Grade 2-vs-Grade 3 |
1.008050E-04 |
Grade 2-vs-Grade 4 |
3.40399930465196E-11 |
Grade 3-vs-Grade 4 |
9.968000E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.63025148935958E-12 |
Normal-vs-ccB subtype |
1.62447832963153E-12 |
ccA subtype-vs-ccB subtype |
2.603200E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.62447832963153E-12 |
Normal-vs-N1 |
6.36880548299246E-11 |
N0-vs-N1 |
1.348570E-01 |
|
|